Related Experiment Video
Updated: Jul 5, 2026
09:30
Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Pharmaceutical GMP: past, present, and future--a review
1Torrent Pharmaceuticals Ltd, R & D Centre, Bhat, Gandhinagar, India. Kalpesh_patel147@rediffmail.com
Die Pharmazie
|May 13, 2008
Summary
Good Manufacturing Practice (GMP) ensures pharmaceutical product quality and safety through global regulations. Understanding GMP history is crucial for compliance and preventing future manufacturing tragedies.
Area of Science:
- Pharmaceutical Manufacturing
- Quality Control
- Regulatory Affairs
Background:
- Good Manufacturing Practice (GMP) encompasses global regulations for pharmaceuticals, medical devices, and food.
- GMP ensures the quality and control of manufacturing and testing processes for pharmaceutical products.
Observation:
- Many GMP requirements originated from tragic events, aiming to prevent recurrence.
- Understanding the historical context of GMP is vital for maintaining compliance.
Findings:
- This review examines the historical evolution, current status, and future trajectory of GMP.
- GMP serves as a critical framework for the pharmaceutical industry worldwide.
Implications:
- Knowledge of GMP precedents is essential for achieving and sustaining compliance.
- The review provides insights into the ongoing importance of GMP in safeguarding public health.
Related Concept Videos
01:26Good Manufacturing Practices
Good Manufacturing Practices (GMP) constitute a foundational set of guidelines that ensure the production of safe, consistent, and high-quality products, particularly in industries such as pharmaceuticals, biotechnology, and food processing. These protocols encompass all aspects of production, from the sourcing of raw materials to the final distribution of the finished product.A core pillar of GMP is stringent hygiene and sanitation across all production environments. This includes routine...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:18Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...